1. Home
  2. HLN vs RLAY Comparison

HLN vs RLAY Comparison

Compare HLN & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Haleon plc (Each representing two)

HLN

Haleon plc (Each representing two)

HOLD

Current Price

$10.02

Market Cap

43.7B

ML Signal

HOLD

Logo Relay Therapeutics Inc.

RLAY

Relay Therapeutics Inc.

HOLD

Current Price

$9.35

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HLN
RLAY
Founded
2022
2015
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Package Goods/Cosmetics
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
43.7B
1.3B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
HLN
RLAY
Price
$10.02
$9.35
Analyst Decision
Buy
Strong Buy
Analyst Count
1
7
Target Price
N/A
$16.86
AVG Volume (30 Days)
8.1M
2.4M
Earning Date
02-26-2026
05-04-2026
Dividend Yield
1.85%
N/A
EPS Growth
N/A
31.78
EPS
N/A
N/A
Revenue
N/A
$15,355,000.00
Revenue This Year
$7.04
N/A
Revenue Next Year
$4.58
$324.03
P/E Ratio
$49.05
N/A
Revenue Growth
N/A
53.44
52 Week Low
$8.71
$1.78
52 Week High
$11.42
$11.49

Technical Indicators

Market Signals
Indicator
HLN
RLAY
Relative Strength Index (RSI) 44.31 44.95
Support Level $9.98 $9.06
Resistance Level $10.31 $9.54
Average True Range (ATR) 0.14 0.63
MACD -0.03 -0.14
Stochastic Oscillator 37.37 0.90

Price Performance

Historical Comparison
HLN
RLAY

About HLN Haleon plc (Each representing two)

Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.

About RLAY Relay Therapeutics Inc.

Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).

Share on Social Networks: